TransGenex Nanobiotech Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

TransGenex Nanobiotech General Information

Description

Developer of nano-scale technologies intended for diagnostic and therapeutic agents against cancers and other inflammatory diseases. The company develops a fiber-inspired scaffold technology platform that enables the development of multicellular tumor spheroids that fully resemble tumors in vivo, providing cancer patients with improved drug discovery and development, as well as better prediction of the clinical efficacy of drugs for personalized cancer treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 13719 North Nebraska Avenue
  • Tampa, FL 33613
  • United States
+1 (813)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 13719 North Nebraska Avenue
  • Tampa, FL 33613
  • United States
+1 (813)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TransGenex Nanobiotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Generating Revenue
4. Accelerator/Incubator 18-Jun-2015 Completed Generating Revenue
3. Grant 01-Jan-2015 Completed Generating Revenue
2. Grant 01-Jan-2009 $427K Completed Startup
1. Grant 01-Jan-2008 $1.03M Completed Startup
To view TransGenex Nanobiotech’s complete valuation and funding history, request access »

TransGenex Nanobiotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of nano-scale technologies intended for diagnostic and therapeutic agents against cancers and other inflammato
Drug Discovery
Tampa, FL
6 As of 2023

Vancouver, Canada
 

Berkeley, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TransGenex Nanobiotech Competitors (3)

One of TransGenex Nanobiotech’s 3 competitors is Aspect Biosystems, a Venture Capital-Backed company based in Vancouver, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aspect Biosystems Venture Capital-Backed Vancouver, Canada
Prellis Biologics Venture Capital-Backed Berkeley, CA
InSphero Private Equity-Backed Schlieren, Switzerland
You’re viewing 3 of 3 competitors. Get the full list »

TransGenex Nanobiotech Patents

TransGenex Nanobiotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200323949-A1 Molecular engineering of a novel ternary complex of actinomycin d for cancer stem cells treatment Inactive 10-Apr-2019
US-20220185767-A1 Novel ternary molecular complex of tamibarotene for cancer stem cells treatment Inactive 02-Apr-2019
WO-2020205957-A1 Novel ternary molecular complex of tamibarotene for cancer stem cells treatment Inactive 02-Apr-2019
US-11319311-B2 Crystalline forms of actinomycin d for treatment of cancer Inactive 13-Feb-2018
US-11053254-B2 Crystalline forms of mitomycin c for treatment of cancer Inactive 13-Feb-2018 C07D487/14
To view TransGenex Nanobiotech’s complete patent history, request access »

TransGenex Nanobiotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TransGenex Nanobiotech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Institute for Commercialization of Florida Technology Not-For-Profit Venture Capital Minority
United States Department of War Government
U.S. Department of Health and Human Services Government
To view TransGenex Nanobiotech’s complete investors history, request access »

TransGenex Nanobiotech FAQs

  • When was TransGenex Nanobiotech founded?

    TransGenex Nanobiotech was founded in 2004.

  • Where is TransGenex Nanobiotech headquartered?

    TransGenex Nanobiotech is headquartered in Tampa, FL.

  • What is the size of TransGenex Nanobiotech?

    TransGenex Nanobiotech has 6 total employees.

  • What industry is TransGenex Nanobiotech in?

    TransGenex Nanobiotech’s primary industry is Drug Discovery.

  • Is TransGenex Nanobiotech a private or public company?

    TransGenex Nanobiotech is a Private company.

  • What is TransGenex Nanobiotech’s current revenue?

    The current revenue for TransGenex Nanobiotech is .

  • Who are TransGenex Nanobiotech’s investors?

    Institute for Commercialization of Florida Technology, United States Department of War, and U.S. Department of Health and Human Services have invested in TransGenex Nanobiotech.

  • Who are TransGenex Nanobiotech’s competitors?

    Aspect Biosystems, Prellis Biologics, and InSphero are competitors of TransGenex Nanobiotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process